---
title: CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop
  that limits CXCL9 expression and antitumor immunity
date: '2023-08-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37605534/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230822180916&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: CXCL9 expression is a strong predictor of response to immune checkpoint
  blockade therapy. Accordingly, we sought to develop therapeutic strategies to enhance
  the expression of CXCL9 and augment antitumor immunity. To perform whole-genome
  CRISPR-Cas9 screening for regulators of CXCL9 expression, a CXCL9-GFP reporter line
  is generated using a CRISPR knockin strategy. This approach finds that IRF1 limits
  CXCL9 expression in both tumor cells and primary myeloid cells through induction
  of ...
disable_comments: true
---
CXCL9 expression is a strong predictor of response to immune checkpoint blockade therapy. Accordingly, we sought to develop therapeutic strategies to enhance the expression of CXCL9 and augment antitumor immunity. To perform whole-genome CRISPR-Cas9 screening for regulators of CXCL9 expression, a CXCL9-GFP reporter line is generated using a CRISPR knockin strategy. This approach finds that IRF1 limits CXCL9 expression in both tumor cells and primary myeloid cells through induction of ...